Neogenomics Stock In The News
| NEO Stock | USD 9.92 0.06 0.61% |
Our overall analysis of NeoGenomics' news coverage and content from conventional and social sources shows investors' bearish mood towards NeoGenomics. The specific impact of NeoGenomics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of NeoGenomics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using NeoGenomics headlines in addition to utilizing other, more conventional financial analysis modules. Check out NeoGenomics Backtesting and NeoGenomics Hype Analysis. To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide NeoGenomics and other traded companies coverage with news coverage. We help investors stay connected with NeoGenomics headlines for the 24th of March to make an informed investment decision based on correlating the impacts of news items on NeoGenomics Stock performance. Please note that trading solely based on the NeoGenomics hype is not for everyone as timely availability and quick action are needed to avoid losses.
NeoGenomics |
NeoGenomics Today Top News and Investor Outlook
NeoGenomics Past News Timeline
NeoGenomics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the NeoGenomics earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about NeoGenomics that are available to investors today. That information is available publicly through NeoGenomics media outlets and privately through word of mouth or via NeoGenomics internal channels. However, regardless of the origin, that massive amount of NeoGenomics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of NeoGenomics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NeoGenomics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NeoGenomics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NeoGenomics alpha.
NeoGenomics Largest EPS Surprises
Earnings surprises can significantly impact NeoGenomics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2011-10-19 | 2011-09-30 | -0.01 | -0.0033 | 0.0067 | 67 | ||
2015-07-23 | 2015-06-30 | -0.01 | -0.0029 | 0.0071 | 71 | ||
2013-02-14 | 2012-12-31 | -0.01 | -0.0023 | 0.0077 | 77 | ||
2009-07-28 | 2009-06-30 | 0.01 | 2.0E-4 | -0.0098 | 98 | ||
2021-11-04 | 2021-09-30 | -0.09 | -0.08 | 0.01 | 11 | ||
2019-10-29 | 2019-09-30 | 0.06 | 0.07 | 0.01 | 16 |
NeoGenomics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to NeoGenomics Stock. Current markets are strongly bearish. About 79% of major world exchanges and indexes are down. See today's market update for more information.
19th of March 2025
IMEON ENERGY annonce le lancement du NEO, sa nouvelle gamme de systmes pour le stockage de... at businesswire.com
18th of March 2025
NeoGenomics Appoints Warren Stone as President Chief Operating Officer at businesswire.com
13th of March 2025
Disposition of 5175 shares by Alicia Olivo of NeoGenomics at 15.3575 subject to Rule 16b-3 at news.google.com
27th of February 2025
Disposition of 11336 shares by Zook Anthony P. of NeoGenomics subject to Rule 16b-3 at thelincolnianonline.com
24th of February 2025
NeoGenomics to Participate in Upcoming Investor Conferences at finance.yahoo.com
20th of February 2025
Wyloo to form Yangibana Joint Venture with Hastings and becomes largest shareholder in Neo... at finance.yahoo.com
18th of February 2025
NeoGenomics reports mixed Q4 earnings reaffirms FY25 outlook at seekingalpha.com
30th of January 2025
Menlo Park-based biotech company welcomes Florida exec to board at bizjournals.com
14th of January 2025
Acquisition by Warren Stone of 59382 shares of NeoGenomics subject to Rule 16b-3 at seekingalpha.com
NeoGenomics Investors Sentiment
The influence of NeoGenomics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in NeoGenomics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to NeoGenomics' public news can be used to forecast risks associated with an investment in NeoGenomics. The trend in average sentiment can be used to explain how an investor holding NeoGenomics can time the market purely based on public headlines and social activities around NeoGenomics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
NeoGenomics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for NeoGenomics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average NeoGenomics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on NeoGenomics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NeoGenomics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NeoGenomics' short interest history, or implied volatility extrapolated from NeoGenomics options trading.
Check out NeoGenomics Backtesting and NeoGenomics Hype Analysis. To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeoGenomics. If investors know NeoGenomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeoGenomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.306 | Earnings Share (0.62) | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
The market value of NeoGenomics is measured differently than its book value, which is the value of NeoGenomics that is recorded on the company's balance sheet. Investors also form their own opinion of NeoGenomics' value that differs from its market value or its book value, called intrinsic value, which is NeoGenomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeoGenomics' market value can be influenced by many factors that don't directly affect NeoGenomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeoGenomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeoGenomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeoGenomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.